Sector
The science and translation of biological aging, healthspan, lifespan extension, geroscience, senescence, cellular reprogramming, regenerative approaches, longevity therapeutics, biological-age measurement, and longevity medicine.
Epigenetic Reprogramming
Therapies reversing epigenetic age and cellular aging
The field
At a glance
Definition
Therapies reversing epigenetic age and cellular aging
Technologies
Yamanaka factors (Oct4, Sox2, Klf4, c-Myc or subsets) reverse epigenetic age when expressed transiently. mRNA delivery provides temporary, controllable reprogramming factor expression. Epigenetic clocks measure the success of reprogramming. Single-cell sequencing assesses reprogramming at cellular resolution. Chemical reprogramming uses small molecules instead of genetic factors.
Applications
Preclinical studies demonstrate tissue rejuvenation through partial reprogramming. Epigenetic clocks measure biological age reduction from reprogramming. mRNA delivery enables transient, controllable reprogramming. Chemical reprogramming avoids genetic manipulation entirely.
Market and funding
Epigenetic reprogramming has attracted $5+ billion in private investment (Altos Labs $3B, Retro Biosciences, NewLimit, Turn Biotechnologies). If successful, the addressable market is unlimited.
Next door
Related sectors
Sector
Biomarkers identifying and tracking biological aging
Sector
Technology enabling seniors to live independently at home
Sector
Technology preserving biological samples and organisms
Sector
Interventions extending healthy years of life
Sector
Medical centers focused on aging research and interventions
Is this page right?How the research works